Screener für Derivate

Partner-Broker

Filter: Derivate

Börse

Alle Länder

Nordamerika

Südamerika

Europa

Afrika

Mittlerer Osten

Asien

Ozeanien

Mittelamerika

Alles auswählen

Emittent

Alle Emittenten
Alles auswählen

Produkttyp

Alle Arten von Produkten
Alles auswählen

Typ

Fälligkeit

Nur für Hebelprodukte verfügbar

Hebel / Elastizität

Filter: Basiswert

ODER

Wertpapierart

Alle Wertpapierarten
Alles auswählen

Land des Wertes

Alle Länder
Alles auswählen

Indizes & Märkte

Alle Länder

Nordamerika

Europa

Asien, Pazifik

Südamerika

Mittlerer Osten

Meine Watchlists

Watchlists
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
Einloggen Registrieren

39 Derivate

d09b272911c7aa59cbb48d29aaa4e4c.Poz57Qaljh5LF3iimFB-sjols7A6WGKS8MjmQdA2LBs.cdSLojSR7U59bi7R7CEI30998sJJCSTdiomMGLcEaS9W_pGpNs3BSnp-QA
WKNBasiswert%TypProdukttyp Fälligkeit Elastizität Hebel ParitätKursEmittent
MB81J5
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.27 EUR

Morgan Stanley
MB81J6
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.167 EUR

Morgan Stanley
MB81J4
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.47 EUR

Morgan Stanley
MB81J7
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.094 EUR

Morgan Stanley
MB8BSS
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.111 EUR

Morgan Stanley
MB8BST
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.084 EUR

Morgan Stanley
MB8Z7U
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.088 EUR

Morgan Stanley
MB9S0J
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.06.2024 - 10

0.082 EUR

Morgan Stanley
ME17Q9
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 6.43x - 10

0.147 EUR

Morgan Stanley
ME17Q7
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 6.31x - 10

0.28 EUR

Morgan Stanley
ME17Q8
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 6.63x - 10

0.188 EUR

Morgan Stanley
ME17Q6
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 5.83x - 10

0.36 EUR

Morgan Stanley
ME1G0S
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 5.25x - 10

0.43 EUR

Morgan Stanley
ME24SD
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 4.67x - 10

0.57 EUR

Morgan Stanley
ME2M2Y
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Warrant Plain-Vanilla 20.09.2024 4.03x - 10

0.74 EUR

Morgan Stanley
ME2PZH
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 3.45x - 10

0.92 EUR

Morgan Stanley
ME489Y
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 6.56x - 10

0.213 EUR

Morgan Stanley
ME66GT
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 4.09x - 10

0.6 EUR

Morgan Stanley
ME66GS
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 3.72x - 10

0.73 EUR

Morgan Stanley
ME66GU
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 4.49x - 10

0.48 EUR

Morgan Stanley
ME66GR
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 3.31x - 10

0.88 EUR

Morgan Stanley
ME66GW
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 5.27x - 10

0.21 EUR

Morgan Stanley
ME66GQ
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 2.97x - 10

1.05 EUR

Morgan Stanley
ME66GV
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 4.74x - 10

0.4 EUR

Morgan Stanley
ME6NDA
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.09.2024 2.99x - 10

1.11 EUR

Morgan Stanley
ME6TJB
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 2.68x - 10

1.23 EUR

Morgan Stanley
ME9A0J
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 5.05x - 10

0.33 EUR

Morgan Stanley
MG1084
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 4.33x - 10

0.32 EUR

Morgan Stanley
MG1082
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 3.61x - 10

0.65 EUR

Morgan Stanley
MG1080
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 3.1x - 10

0.9 EUR

Morgan Stanley
MG1081
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 3.38x - 10

0.76 EUR

Morgan Stanley
MG1083
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 3.87x - 10

0.55 EUR

Morgan Stanley
MG107Z
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 2.84x - 10

1.05 EUR

Morgan Stanley
MG29QT
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 2.6x - 10

1.2 EUR

Morgan Stanley
MG3TGQ
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 4.03x - 10

0.45 EUR

Morgan Stanley
MG41G4
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 4.19x - 10

0.4 EUR

Morgan Stanley
MG41G3
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 5.11x - 10

0.28 EUR

Morgan Stanley
MG4DME
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 20.12.2024 5.21x - 10

0.25 EUR

Morgan Stanley
MG4DMD
HALOZYME THERAPEUTICS, INC. CALL
HALOZYME THERAPEUTICS, INC. Aktie Halozyme Therapeutics, Inc.
+1.72% CALL Plain-Vanilla-Warrants 21.03.2025 4.26x - 10

0.36 EUR

Morgan Stanley
  1. Börse
  2. Derivate
  3. Screener
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT